Ophthalmology, Dobry Wzrok Ophthalmological Clinic, Poland
Dr. Maciej Gawęcki, MD, PhD, is a prominent Polish ophthalmologist known for his pioneering work in laser therapy for retinal diseases. A graduate of the Medical University of Gdańsk, he has led major ophthalmology departments across Poland. Currently, he heads the Department of Ophthalmology at Pomeranian Hospitals in Wejherowo and serves as the Regional Consultant in Ophthalmology for the Pomorskie Region. His clinical practice integrates cutting-edge diagnostics and surgical techniques, with a particular focus on subthreshold laser therapies and retinal imaging innovations. 📍
Profile
Google scholar
🎓 Education
Dr. Gawęcki completed his medical studies at the Medical University of Gdańsk in 1994, followed by his specialization in ophthalmology in 2001. That same year, he defended his PhD thesis titled “Amblyopia without strabismus.” He received a prestigious scholarship from the European Ophthalmological Society, which he pursued at Moorfields Eye Hospital, London, in 1999. In 2021, he earned his habilitation with a dissertation on “The use of micropulse laser in the treatment of central serous chorio-retinopathy.” 🎓📘
💼 Experience
Between 2002 and 2006, Dr. Gawęcki served as Deputy Head of the Department of Ophthalmology at the Regional Hospital in Elbląg. From 2007 to 2023, he led the ophthalmology department at the Specialist Hospital in Chojnice. He now leads the Department of Ophthalmology at Pomeranian Hospitals in Wejherowo. Since 2015, he has been the Regional Consultant in Ophthalmology for the Pomorskie Region. His leadership spans over two decades of advancing clinical ophthalmology in Poland. 👨⚕️🏥
🔬 Research Interest
Dr. Gawęcki’s research interests focus on modern ophthalmic diagnostic and treatment techniques, including fluorescein and indocyanine green angiography, optical coherence tomography (OCT), angio-OCT, and subthreshold laser therapies. He is highly active in clinical trials and innovations in retinal laser therapies and surgical interventions for cataracts and strabismus. His passion lies in integrating imaging technologies with effective, minimally invasive treatments. 🧪👁️
🏆 Awards
Dr. Gawęcki has received recognition for his clinical and academic excellence, including a European Ophthalmological Society scholarship in 1999. His habilitation and numerous leadership roles underline his status as an expert in ophthalmic care and research. He is frequently invited to conferences and symposia, contributing significantly to the field of medical ophthalmology. 🥇📜
📚 Publications
Micropulse laser treatment of retinal diseases – Journal of Clinical Medicine, 2019, Cited by: 93
Functional and morphological outcome in patients with chronic central serous chorioretinopathy – Graefe’s Archive, 2017, Cited by: 57
Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy – BMC Ophthalmology, 2019, Cited by: 36
Transfoveal micropulse laser treatment of central serous chorioretinopathy – Journal of Clinical Medicine, 2019, Cited by: 35
Current management options in Irvine–Gass syndrome: a systemized review – Journal of Clinical Medicine, 2021, Cited by: 31
Threshold values of myopic anisometropia causing loss of stereopsis – Journal of Ophthalmology, 2019, Cited by: 31
Subthreshold diode micropulse laser combined with intravitreal therapy – Journal of Clinical Medicine, 2021, Cited by: 24
Conclusion 💬
Dr. Maciej Gawęcki is a highly qualified clinician-researcher with a distinguished record in ophthalmology, particularly in retinal diagnostics and laser therapy. His longstanding contributions to clinical leadership, regional policy, and applied research showcase a mature and impactful career. While there’s room for expanding his global academic footprint, his current credentials and dedication to innovation and education make him a strong candidate for the Best Researcher Award.